T regulatory cells, the evolution of targeted immunotherapy

被引：34
|
作者：
Nizar, S. [1 ,2 ]
Meyer, B. [1 ]
Galustian, C. [1 ]
Kumar, D. [2 ]
Dalgleish, A. [1 ]
机构：
[1] St Georges Univ London, Dept Cellular & Mol Med, London SW17 0RE, England
[2] St Georges Hosp NHS Trust, Dept Colorectal Surg, London, England
来源：
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2010年 / 1806卷 / 01期
关键词：
T regulatory; Tregs; FOXP3; Cancer; Immunotherapy; PHASE-II TRIAL; DENILEUKIN DIFTITOX; DENDRITIC CELLS; ANTITUMOR IMMUNITY; CTLA-4; BLOCKADE; TGF-BETA; PERIPHERAL-BLOOD; PROSTATE-CANCER; FUSION PROTEIN; IN-VITRO;
D O I：
10.1016/j.bbcan.2010.02.001
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
T regulatory cells are able to suppress anti-tumour immunity in pre-clinical models and in patients. This review highlights the important discoveries in Treg immunology critical to the evolution of targeted immunotherapy. We also describe the therapeutic applications that are currently being assessed and their future potential. (C) 2010 Elsevier BM. All rights reserved.
引用
收藏
页码：7 / 17
页数：11
相关论文
共 50 条
  • [31] Non-coding RNA in tumor-infiltrating regulatory T cells formation and associated immunotherapy
    Ma, Yue
    Xu, Xin
    Wang, Huaitao
    Liu, Yang
    Piao, Haiyan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [32] Regulatory T cells: a potential target in cancer immunotherapy
    Shitara, Kohei
    Nishikawa, Hiroyoshi
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2018, 1417 (01) : 104 - 115
  • [33] Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells
    Alissafi, T.
    Hatzioannou, A.
    Legaki, A. I.
    Varveri, A.
    Verginis, Panayotis
    JOURNAL OF AUTOIMMUNITY, 2019, 104
  • [34] The Tolerogenic Function of Regulatory T Cells in Pregnancy and Cancer
    Jorgensen, Nanna
    Persson, Gry
    Hviid, Thomas Vauvert F.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [35] Regulatory T Cells in Autoimmunity and Cancer: A Duplicitous Lifestyle
    Hatzioannou, Aikaterini
    Boumpas, Athina
    Papadopoulou, Miranta
    Papafragkos, Iosif
    Varveri, Athina
    Alissafi, Themis
    Verginis, Panayotis
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [36] T regulatory cells as an immunotherapy for transplantation
    Albert, MH
    Anasetti, C
    Yu, XZ
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (04) : 315 - 324
  • [37] Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy
    Dees, Sundee
    Ganesan, Rajkumar
    Singh, Sanjaya
    Grewal, Iqbal S.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 (02) : 280 - 291
  • [38] Molecular insights into the development of T cell-based immunotherapy for prostate cancer
    Dong, Baijun
    Minze, Laurie J.
    Xue, Wei
    Chen, Wenhao
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (11) : 1547 - 1557
  • [39] Adoptive immunotherapy with the use of regulatory T cells and virus-specific T cells derived from cord blood
    Hanley, Patrick J.
    Bollard, Catherine M.
    Brunstein, Claudio G.
    CYTOTHERAPY, 2015, 17 (06) : 749 - 755
  • [40] Regulatory T cells and potential inmmunotherapeutic targets in lung cancer
    Zhang, Ding
    Chen, Zhihong
    Wang, Diane C.
    Wang, Xiangdong
    CANCER AND METASTASIS REVIEWS, 2015, 34 (02) : 277 - 290
12345